Medpace

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell Medpace and other ETFs, options, and stocks.

About MEDP

Medpace Holdings, Inc. engages in the provision of outsourced clinical development services to the biotechnology, pharmaceutical, and medical device industries. The firm's services include medical department, clinical trial management, data-driven feasibility, study-start-up, clinical monitoring, regulatory affairs, patient recruitment and retention, medical writing, biometrics and data sciences, pharmacovigilance, core laboratory, laboratories, clinics, and quality assurance. 

CEO
August James Troendle
CEOAugust James Troendle
Employees
6,200
Employees6,200
Headquarters
Cincinnati, Ohio
HeadquartersCincinnati, Ohio
Founded
1992
Founded1992
Employees
6,200
Employees6,200

MEDP Key Statistics

Market cap
16.82B
Market cap16.82B
Price-Earnings ratio
33.63
Price-Earnings ratio33.63
Dividend yield
Dividend yield
Average volume
332.90K
Average volume332.90K
High today
$594.99
High today$594.99
Low today
$582.08
Low today$582.08
Open price
$590.45
Open price$590.45
Volume
124.96K
Volume124.96K
52 Week high
$677.90
52 Week high$677.90
52 Week low
$373.00
52 Week low$373.00

Stock Snapshot

With a market cap of 16.82B, Medpace(MEDP) trades at $590.67. The stock has a price-to-earnings ratio of 33.63.

As of 2026-08-09, Medpace(MEDP) stock has fluctuated between $582.08 and $594.99. The current price stands at $590.67, placing the stock +1.5% above today's low and -0.7% off the high.

Medpace(MEDP) shares are trading with a volume of 124.96K, against a daily average of 332.9K.

During the past year, Medpace(MEDP) stock moved between $373.00 at its lowest and $677.90 at its peak.

During the past year, Medpace(MEDP) stock moved between $373.00 at its lowest and $677.90 at its peak.

MEDP News

Zacks 2d
Medpace Just Flashed Golden Cross Signal: Do You Buy? - Zacks Investment Research

...

Medpace Just Flashed Golden Cross Signal: Do You Buy? - Zacks Investment Research
Simply Wall St 3d
Medpace Holdings Updates 2026 Guidance, Is The Upside Already Priced In?

Advertisement Medpace Holdings guidance update and why it matters now Medpace Holdings (MEDP) recently updated its 2026 guidance, telling investors to expect...

Medpace Holdings Updates 2026 Guidance, Is The Upside Already Priced In?

Analyst ratings

73%

of 15 ratings
Buy
13.3%
Hold
73.3%
Sell
13.3%

People also own

Based on the portfolios of people who own MEDP. This list is generated using Robinhood data, and it’s not a recommendation.

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.

All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer. Options are risky and aren’t suitable for all investors. To learn more about risks, read the Options Disclosure Document.